Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines. [electronic resource]
Producer: 20111215Description: 436-45 p. digitalISSN:- 1873-2496
- Blotting, Western
- Butadienes -- pharmacology
- Cell Differentiation -- drug effects
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Chromones -- pharmacology
- Dose-Response Relationship, Drug
- Enzyme Inhibitors -- pharmacology
- Fluorescent Antibody Technique
- Humans
- Male
- Mitogen-Activated Protein Kinase 1 -- antagonists & inhibitors
- Mitogen-Activated Protein Kinase 3 -- antagonists & inhibitors
- Morpholines -- pharmacology
- Neurosecretory Systems -- pathology
- Nitriles -- pharmacology
- Phosphatidylinositol 3-Kinases -- metabolism
- Phosphoinositide-3 Kinase Inhibitors
- Phosphorylation -- drug effects
- Piperazines -- pharmacology
- Prostatic Neoplasms -- metabolism
- Proto-Oncogene Proteins c-akt -- metabolism
- Serotonin -- pharmacology
- Serotonin Antagonists -- pharmacology
- Serotonin Receptor Agonists -- pharmacology
- Signal Transduction -- drug effects
- Time Factors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.